Welcome to our dedicated page for Genpact SEC filings (Ticker: G), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Genpact's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Genpact's regulatory disclosures and financial reporting.
Genpact LTD’s Chief Financial Officer, Michael Hal Weiner, reported acquiring 17,320 common shares on March 3, 2026 through a grant/award transaction at a price of $0.00 per share. These shares relate to performance share units granted on March 15, 2023, for which performance conditions have been satisfied. The performance share units will vest on March 10, 2026, subject to his continued service. Following this award, he beneficially owns 188,893 common shares, including 1,538 shares held under the Genpact Employee Stock Purchase Plan, of which 102 were acquired since his Form 4 filed on February 3, 2026.
Genpact Limited, a Bermuda-based advanced technology and business process company, reports 2025 total net revenues of $5.1 billion. Advanced Technology Solutions generated $1.2 billion, or 23.7% of net revenues, while Core Business Services contributed $3.9 billion, or 76.3%.
The company is pivoting heavily into AI and agentic solutions, embedding data and AI, digital technology and advisory services across its offerings. By industry, 2025 revenues were $1.4 billion from Financial Services (26.7%), $1.7 billion from Consumer and Healthcare (34.0%), and $2.0 billion from High Tech and Manufacturing (39.3%).
Genpact employs over 146,500 people in more than 35 countries and is scaling AI talent, with over 7,000 AI builders and nearly 20,000 AI practitioners. The company highlights significant risks around rapid AI adoption, cybersecurity, regulatory change, talent retention—its 2025 attrition rate was 24%—and geopolitical and economic uncertainty.
Genpact Limited furnished a Form 8-K to provide a press release announcing its financial results for the three months and full year ended December 31, 2025. The press release is included as Exhibit 99.1 and is incorporated by reference.
The company notes that the press release and related conference call include non-GAAP financial measures, and that reconciliations to the most directly comparable GAAP figures are provided in the press release. The information under Item 2.02 is furnished, not filed, so it is not subject to certain Exchange Act liabilities or automatically incorporated into other SEC filings.
Genpact Limited’s Chief Accounting Officer, Anthony J. Radesca, received an equity grant of 6,802 common shares on January 30, 2026, at a price of $0 per share. The award is in the form of restricted share units under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.
Each RSU converts into one Genpact common share upon vesting. One-third of the shares will vest on each of January 10, 2027, January 10, 2028, and January 10, 2029, contingent on his continued service. Following this grant, he beneficially owns 26,868 common shares directly.
Genpact Limited reported that SVP and Chief Legal Officer Sydney Schaub received an equity award in the form of restricted share units. On January 30, 2026, Schaub was granted 12,471 common shares at a price of $0, increasing her directly held beneficial ownership to 75,828 common shares.
The award consists of unvested restricted share units granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU converts into one common share upon vesting. One-third of the RSUs will vest on each of January 10, 2027, January 10, 2028, and January 10, 2029, subject to her continued service through each vesting date.
Genpact Limited Senior Vice President Sameer Dewan reported an equity award of 16,530 common share units on January 30, 2026. The filing shows these shares at a price of $0, reflecting a grant of unvested restricted share units under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.
Each RSU converts into one Genpact common share as it vests. One-third of the award will vest on each of January 10, 2027, January 10, 2028, and January 10, 2029, contingent on continued service. Following this grant, Dewan beneficially owns 54,279 common shares directly.
Genpact Limited Senior Vice President Anil Nanduru received an equity award of 21,371 common shares in the form of restricted share units on January 30, 2026. The award was granted at a price of $0 per share and increased his beneficially owned common shares to 99,346, held directly.
The RSUs were granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU converts into one common share upon vesting. One-third of the shares will vest on each of January 10, 2027, January 10, 2028, and January 10, 2029, if he continues in service through each vesting date.
Genpact Limited’s President and CEO, Balkrishan Kalra, reported an equity compensation grant in the form of restricted share units. On January 30, 2026, he was awarded 106,575 common shares at a price of $0 per share, increasing his beneficial ownership to 497,260 common shares, held directly.
The award represents unvested restricted share units under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU converts into one common share upon vesting. One-third of the shares will vest on each of January 10, 2027, January 10, 2028 and January 10, 2029, contingent on his continued service through each vesting date.
Genpact Limited reported that Senior Vice President and Chief Human Resources Officer Piyush Mehta received an award of 24,716 common shares on January 30, 2026 at a price of $0 per share, reflecting a grant under the company’s 2017 Omnibus Incentive Compensation Plan.
The award represents unvested restricted share units, each convertible into one common share upon vesting. One-third of the units will vest on each of January 10, 2027, January 10, 2028 and January 10, 2029, subject to Mehta’s continued service. Following this grant, he beneficially owns 147,416 common shares directly.